Beyond Tumor Accumulation: Molecularly Targeted and Activatable Photoacoustic Contrast Agents
Bioconjugate Chemistry · 2026
DOI: 10.1021/acs.bioconjchem.6c00386 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2026. Verfasst von Dawei Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Southern University of Science and Technology, Shenzhen518055, China. Hauptthemen laut MEDLINE: Contrast Media, Molecular Imaging, Neoplasms, Photoacoustic Techniques. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Photoacoustic imaging (PAI) combines optical absorption with ultrasonic detection and has emerged as a powerful platform for noninvasive molecular imaging. The clinical value of a photoacoustic contrast agent (PACA) is not only determined by tumoral accumulation, but also by whether it can generate sufficient target-to-background contrast. In practice, PACAs can be designed to detect tumor-associated biomarkers in two complementary strategies. Molecularly targeted PACAs rely on specific biological recognition to enhance probe localization or retention, whereas an activatable probe generates photoacoustic signals only in response to a disease-related biochemical trigger. Recent studies further show that molecular targeting and activatable sensing can be integrated within a single probe, for example, by combining receptor recognition with activatable, ratiometric, or photo switchable signal generation. We argue that next-generation PACAs should move beyond maximizing tumor uptake toward maximizing biologically informative target-to-background contrast under clinically realistic imaging conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Southern University of Science and Technology, Shenzhen518055, China.
- Department of Ultrasonography, Peking University Shenzhen Hospital, Shenzhen, Guangdong518036, China.
- Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, Guangdong518055, China.
- School of Light Industry Science and Engineering, Beijing Technology and Business University, Beijing100048, China.
- Department of Biomedical Engineering, College of Future Technology, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing100871, China.
ORCID-Profile: Zhifei Dai, Desheng Sun
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Zhou, D., Dan, Q., Xi, L., Xu, Y., Dai, Z., & Sun, D. (2026). Beyond Tumor Accumulation: Molecularly Targeted and Activatable Photoacoustic Contrast Agents. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.6c00386
Vancouver
Zhou D, Dan Q, Xi L, Xu Y, Dai Z, Sun D. Beyond Tumor Accumulation: Molecularly Targeted and Activatable Photoacoustic Contrast Agents. Bioconjugate Chemistry. 2026. doi:10.1021/acs.bioconjchem.6c00386
BibTeX
@article{Zhou2026,
author = {Zhou, Dawei and Dan, Qing and Xi, Lei and Xu, Yunxue and Dai, Zhifei and Sun, Desheng},
title = {Beyond Tumor Accumulation: Molecularly Targeted and Activatable Photoacoustic Contrast Agents},
journal = {Bioconjugate Chemistry},
year = {2026},
doi = {10.1021/acs.bioconjchem.6c00386}
}
EUVIMED